Healthcare Execs Are Increasingly Relying On Technology

By Admin
Healthcare executives are becoming increasingly more reliant on healthcare technology, according tonew researchfromThe Economistand RICOH Europe. The s...

Healthcare executives are becoming increasingly more reliant on healthcare technology, according to new research from The Economist and RICOH Europe.

The study received 432 responses from healthcare executives and close to 93 percent said that they've become more reliant on technology and they're positive about the impact it's having on the industry. Approximately 70 percent said the increased use of technology has increased employees' creativity, while 65 percent agreed there is even more room for efficiency gains.

Read Related Articles On Healthcare Global

Interestingly, 35 percent of respondents admitted that a computer-automated decision has cost their organization money recently. An accompanying infographic highlights the numbers.

The respondents said that technology challenges have included evolution that occurs more quickly than internal processes that support it, and poor connectivity. Human intuition, they added, remains necessary for diagnosing patients and developing new treatments and medicines. Only eight percent of those surveyed think human imagination or intuition is needed for management of patient records.

Human resistance to change and difficulty in adapting new technologies are prominent reasons why interacting with new technologies can be a hard transition, states the report. “While technology may augment human potential in some healthcare domains, in others it is being viewed as a means to free up people to perform other activities,” it stated.

READ THE APRIL ISSUES OF HEALTHCARE GLOBAL HERE

 

Share
Share

Featured Articles

Grifols & Orange Business Launch Egypt Plasma Project

Grifols & Orange Business Complete landmark phase of Data Centre for Plasma Derivatives Facility, designed to boost healthcare in Egypt

Healthcare business roundup: Eli Lilly, Novo Nordisk, Aspen

Eli Lilly's experimental cardiovascular drug ‘promising’; Aspen Pharmacare to manufacture mpox vaccines; Novo Nordisk says Ozempic shortage ‘worsening’

Global Health Funding 'Facing Post-Pandemic Challenges'

IHME report highlights shifting priorities and economic pressures affecting global health financing, despite increase in funding since pre-COVID levels

The Merck Group: Pharma's History & Innovation in India

Medical Devices & Pharma

How CVS Health is Rising to the Omnichannel Challenge

Procurement & Supply Chain

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Procurement & Supply Chain